ClassID:

94871

C07D295/116 - CPC Classification

Classification description:

Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings with the doubly bound oxygen or sulfur atoms directly attached to a carbocyclic ring

Recent Application in this class:
#1
20240409508
2024-12-12

SULFINYLAMINOBENZAMIDE AND SULFONYLAMINOBENZAMIDE DERIVATIVES

#2
20240092738
2024-03-21

N,N diethyl-N'phenylpiperazine alpha 7 and alpha 9 nicotinic acetylcholine receptor agonists and antagonists

#3
20230095032
2023-03-30

N,N diethyl-N'phenylpiperazine alpha 7 and alpha 9 nicotinic acetylcholine receptor agonists and antagonists

#4
20220251036
2022-08-11

DIFLUOROHALOALLYLAMINE SULFONE DERIVATIVE INHIBITORS OF LYSYL OXIDASES, METHODS OF PREPARATION, AND USES THEREOF

#5
20220055985
2022-02-24

Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives

#6
20210179542
2021-06-17

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

#7
20190359565
2019-11-28

Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives

#8
20190270699
2019-09-05

4-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

#9
20190209574
2019-07-11

Substituted 2, 3-dihydro-1H-inden-1-one retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis

#10
20190077790
2019-03-14

4-cyano-benzyl carbamimidoylcarbamate derivatives and their use as AOC3 inhibitors

#11
20190071380
2019-03-07

Naphthoquinones, pro-drugs, and methods of use thereof

#12
20180079711
2018-03-22

Glaucocalyxin a derivative and preparation method and application thereof

#13
20180078545
2018-03-22

METHODS FOR TREATING CANCER WITH TRKA RECEPTOR TYROSINE KINASE ANTAGONISTS

#14
20170327509
2017-11-16

TWO-PHOTON ABSORBING FLUOROPHORES AND METHOD FOR CELLULAR IMAGING USING THE SAME

#15
20170313649
2017-11-02

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

#16
20170145121
2017-05-25

Polymerization initiator and radically polymerizable composition containing same

#17
20160318862
2016-11-03

SYNTHESIS OF DELTA 12-PGJ3 AND RELATED COMPOUNDS

#18
20160304478
2016-10-20

NOVEL COMPOUNDS

#19
20160228431
2016-08-11

Methods for treating cancer with TrkA receptor tyrosine kinase antagonists

#20
20160213627
2016-07-28

Substituted 2,3-dihydro-1H-inden-1-one Retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis

#21
20160185743
2016-06-30

15-oxospiramilactone derivatives, preparation method and uses thereof

#22
20160075638
2016-03-17

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

#23
20150218132
2015-08-06

TrkA receptor tyrosine kinase antagonists and uses thereof

#24
20150152056
2015-06-04

Curcumin analogs and methods of making and using thereof

#25
20150105552
2015-04-16

Synthesis of chiral enaminones, their derivatives, and bioactivity studies thereof

#26
20150072980
2015-03-12

Substituted 2,3-dihydro-1-inden-1-one retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis

#27
20140249181
2014-09-04

Tropolone compounds for treating or preventing retroviral infection

#28
20140186329
2014-07-03

POLYPHENOL ANALOGS TO TREAT ISCHEMIA

#29
20140163024
2014-06-12

Benzyl sulfonamide derivatives as RORc modulators

#30
20140039184
2014-02-06

Phenalene-1-one derivatives, method for producing same and use thereof

#31
20130211080
2013-08-15

Process for the manufacture of TMHQ

#32
20130096105
2013-04-18

Arylsulfonamide based matrix metalloprotease inhibitors

#33
20120258954
2012-10-11

Arylsulfonamide based matrix metalloprotease inhibitors

#34
20120196852
2012-08-02

Inhibitors of methionine aminopeptidases and methods of treating disorders

#35
20120122934
2012-05-17

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

#36
20110059972
2011-03-10

1,4-naphthoquinones derivatives and therapeutic use thereof

#37
20110014186
2011-01-20

Arylsulfonamide-based matrix metalloprotease inhibitors

#38
20100298328
2010-11-25

1-Heterocyclylamino-2-Hydroxy-3-Amino-Omega-Arylalkanes

#39
20100228015
2010-09-09

PRODRUG DERIVATIVES OF ACIDS USING ALCOHOLS WITH HOMOTOPIC HYDROXY GROUPS AND METHODS FOR THEIR PREPARATION AND USE

#40
20100064450
2010-03-18

Agent for dyeing keratin-containing fibers

#41
20090175809
2009-07-09

Merocyanine derivatives for cosmetic use

#42
20090156589
2009-06-18

1,2-DI(CYCLIC GROUP)SUBSTITUTED BENZENE DERIVATIVE

#43
20090118257
2009-05-07

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

#44
20080300274
2008-12-04

Pyrrolidino-1,4-naphthoquinone deriviatives and their use for treating malignancies and cardiovascular diseases

#45
20080124285
2008-05-29

Merocyanine derivatives for cosmetic use

#46
20080015169
2008-01-17

Amino-methyl substituted tetracycline compounds

#47
20070254920
2007-11-01

Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use

#48
20070142399
2007-06-21

Dual function drugs and uses thereof

#49
20060281747
2006-12-14

1,2-di(cyclic) substituted benzene derivatives

#50
20060276465
2006-12-07

1,2-di(cyclic) substituted benzene compounds

#51
20060173044
2006-08-03

Substituted propargylamines

#52
20060173015
2006-08-03

Cyclohexyldiamines as selective alpha 1a/1d adrenoreceptor antagonists for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms

#53
20050026875
2005-02-03

Amino-methyl substituted tetracycline compounds